205 related articles for article (PubMed ID: 20157915)
1. Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization.
Sheng C; Wang W; Che X; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
ChemMedChem; 2010 Mar; 5(3):390-7. PubMed ID: 20157915
[TBL] [Abstract][Full Text] [Related]
2. New azoles with potent antifungal activity: design, synthesis and molecular docking.
Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
[TBL] [Abstract][Full Text] [Related]
3. Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues.
Chen SH; Sheng CQ; Xu XH; Jiang YY; Zhang WN; He C
Biol Pharm Bull; 2007 Jul; 30(7):1246-53. PubMed ID: 17603162
[TBL] [Abstract][Full Text] [Related]
4. Discovery of highly potent novel antifungal azoles by structure-based rational design.
Wang W; Sheng C; Che X; Ji H; Cao Y; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2009 Oct; 19(20):5965-9. PubMed ID: 19748782
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
[TBL] [Abstract][Full Text] [Related]
6. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
Doğan İS; Saraç S; Sari S; Kart D; Eşsiz Gökhan Ş; Vural İ; Dalkara S
Eur J Med Chem; 2017 Apr; 130():124-138. PubMed ID: 28242548
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the combination mode of azoles antifungal inhibitors with CACYP51 and the influence of Site-directed mutation.
Sun B; Huang W; Liu M
J Mol Graph Model; 2017 May; 73():157-165. PubMed ID: 28282632
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14alpha-demethylase (CYP51) of fungi.
Zhu J; Lu J; Zhou Y; Li Y; Cheng J; Zheng C
Bioorg Med Chem Lett; 2006 Oct; 16(20):5285-9. PubMed ID: 16905318
[TBL] [Abstract][Full Text] [Related]
10. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
[TBL] [Abstract][Full Text] [Related]
11. Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.
Lewis DF; Wiseman A; Tarbit MH
J Enzyme Inhib; 1999; 14(3):175-92. PubMed ID: 10445042
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and microbiological evaluation of new Candida albicans CYP51 inhibitors.
Schiaffella F; Macchiarulo A; Milanese L; Vecchiarelli A; Costantino G; Pietrella D; Fringuelli R
J Med Chem; 2005 Dec; 48(24):7658-66. PubMed ID: 16302806
[TBL] [Abstract][Full Text] [Related]
13. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Xu J; Cao Y; Zhang J; Yu S; Zou Y; Chai X; Wu Q; Zhang D; Jiang Y; Sun Q
Eur J Med Chem; 2011 Jul; 46(7):3142-8. PubMed ID: 21420761
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles.
Trösken ER; Adamska M; Arand M; Zarn JA; Patten C; Völkel W; Lutz WK
Toxicology; 2006 Nov; 228(1):24-32. PubMed ID: 16989930
[TBL] [Abstract][Full Text] [Related]
16. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
17. Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole.
Rupp B; Raub S; Marian C; Höltje HD
J Comput Aided Mol Des; 2005 Mar; 19(3):149-63. PubMed ID: 16059669
[TBL] [Abstract][Full Text] [Related]
18. Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
Warrilow AG; Parker JE; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2013 Mar; 57(3):1352-60. PubMed ID: 23274672
[TBL] [Abstract][Full Text] [Related]
19. Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
Keniya MV; Sabherwal M; Wilson RK; Woods MA; Sagatova AA; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126961
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding.
Sheng C; Miao Z; Ji H; Yao J; Wang W; Che X; Dong G; Lü J; Guo W; Zhang W
Antimicrob Agents Chemother; 2009 Aug; 53(8):3487-95. PubMed ID: 19470512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]